Developer docs
API playgroundTry for free, no card

Search company profiles

Inogen

Full company profile

uuid000664y

Namestring
Inogen
Legal namestring
Inogen, Inc.
Company typeenum
Public
Founded yearint
2001
Descriptiontext

Inogen, Inc. (NASDAQ:INGN) is a publicly traded medical device company founded in 2001 and headquartered in Beverly, Massachusetts, that manufactures portable oxygen concentrators (POCs) and related respiratory care equipment. Its core technology centers on proprietary Intelligent Delivery Technology, a pulse-dose oxygen delivery system that detects inspiration and delivers oxygen within the first 250 milliseconds of breath, with replaceable sieve beds that customers can swap in the field. The current product portfolio includes the Inogen One G5, Rove 4, and Rove 6 portable concentrators, the Voxi 5 stationary concentrator, the newly launched Aurora CPAP mask family for sleep apnea, and the Simeox airway clearance technology acquired from Physio-Assist in 2023. The Inogen Connect mobile app provides fleet management, device monitoring, and software updates over Bluetooth.

Inogen sells primarily through a B2B go-to-market model targeting Home Medical Equipment (HME) providers in the United States and international distributors across 59 countries, with pricing conducted via quote-based sales rather than published list pricing. Revenue is generated predominantly through hardware sales of POCs and accessories, supplemented by US rental income (which declined 8% in the most recent reporting period) and an emerging CPAP accessories stream. The company has sold more than one million POC units cumulatively, employs 251-500 people, and operates a European subsidiary (Inogen Europe BV) in the Netherlands. Inogen is debt-free with $120.9 million in cash as of Q4 2025 and holds 31 US patents plus one Canadian patent covering its core device technology.

FY2025 revenue was approximately $349 million (4% YoY growth), with Q1 2026 revenue of $85.1 million and FY2026 guidance of $366-$373 million. International revenue grew 15-18% YoY, and unit volume grew approximately 20% on market conversion from traditional oxygen tanks to POCs. The company remains EBITDA-negative (-$9.5M in 2025) but has shown a clear profitability turnaround from 2023's -$45.7M EBITDA loss. Recent strategic activity includes the 2023 Physio-Assist acquisition, the January 2026 Aurora CPAP launch, the May 2026 Brazil launch of Rove 6, a $30 million share repurchase program authorized in February 2026, and leadership changes in early 2026 (new CFO, CMO, VP B2B Sales, and board director Vafa Jamali) associated with a cooperation agreement with activist investor Kent Lake Partners LP.

Short descriptiontext

Inogen (NASDAQ:INGN) is a publicly traded medical device manufacturer founded in 2001 that designs, produces, and sells portable oxygen concentrators, stationary oxygen systems, CPAP masks, and airway clearance technology, selling primarily through B2B channels to Home Medical Equipment providers and international distributors across 59 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBeverly, United States
HQ citystring
Beverly
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
portable oxygen concentrators, respiratory care devices, home medical equipment, oxygen therapy systems, medical device manufacturing
Industry3 codes
PRIMARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHSABAKAD
Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
SECONDARYHLAHAGAG
Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code2 codes
  • Home Health Equipment Rental532283
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Portable Oxygen Concentrators
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Portable Oxygen Concentrator Sales
TypeHardware Sales
Description

Inogen generates revenue primarily through the sale of portable oxygen concentrators (POCs) to HME providers. The company sells a range of products including the Inogen One G5, Rove 4, Rove 6, and Voxi 5 stationary concentrators, along with accessories and replacement parts.

provider.inogen.com
2Oxygen Therapy Rentals
TypeSubscription Recurring
Description

The company generates revenue from rentals of oxygen therapy equipment in the U.S. market, though U.S. rentals declined 8% due to fewer patients on service.

stocktitan.net
3Accessories and Replacement Parts
TypeHardware Sales
Description

Sales of accessories including batteries, power supplies, carry bags, backpacks, and replacement columns/sieve beds for the POC product line.

provider.inogen.com
4CPAP Masks
TypeHardware Sales
Description

Aurora CPAP masks launched in January 2026, representing the company's expansion into the sleep apnea market with full face, nasal cushion, and nasal pillows options.

medicaleconomics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Contact sales for all product pricing
ModelOtherBilling cadencePay-as-you-go
Notes

No public pricing available - all inquiries directed to sales team via contact form or phone (855-631-2438)

provider.inogen.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Aurora Masks
Description

CPAP masks for obstructive sleep apnea treatment, including F1 Full Face, N1 Nasal Cushion, and P1 Nasal Pillows models

provider.inogen.com
+4 more records
Core offering1 text field

Inogen manufactures and sells portable oxygen concentrators (POCs), stationary oxygen concentrators, CPAP masks, and airway clearance technology primarily through a B2B model targeting Home Medical Equipment (HME) providers in the US and internationally across 59 countries. The company's core POC lineup includes the Inogen One G5, Rove 4, and Rove 6 systems, all featuring proprietary Intelligent Delivery Technology for breath-triggered oxygen delivery. Inogen is also an accredited homecare provider offering oxygen therapy equipment rentals directly to US patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 19% lower mortality risk associated with high mobility POC group vs low mobility POC group
+3 more records
Product overview1 text field

Inogen provides a portfolio of respiratory care products centered on portable oxygen concentrators (POCs) and stationary oxygen systems, supplemented by sleep apnea masks and airway clearance technology acquired through the Physio-Assist acquisition. The core portable oxygen concentrator lineup includes the Inogen One G5 (6-flow settings, up to 1260 ml/min), Rove 4 (4-flow settings, up to 840 ml/min), and Rove 6 (6-flow settings, up to 1260 ml/min), all featuring proprietary Intelligent Delivery Technology for breath-triggered oxygen delivery. The stationary Voxi 5 delivers continuous flow oxygen (1-5 L/min) for home use. The Aurora CPAP mask family (F1 Full Face, N1 Nasal, P1 Nasal Pillows) marks Inogen's entry into sleep apnea therapy. The acquired Simeox technology addresses airway clearance for bronchiectasis. The Inogen Connect mobile app enables patients and providers to monitor device health, track fleet operations, and receive software updates.

Product and service2 records
1Inogen One G5 System
CategoryPortable Oxygen Concentrator
Description

Portable oxygen concentrator with six flow settings delivering up to 1260 ml of medical-grade oxygen per minute. Weighs 2.2 kg (4.7 lbs) with single battery. Features Intelligent Delivery Technology with breath detection for oxygen delivery within first 250 milliseconds of inspiration. Expected service life up to 8 years.

2Inogen Rove 6 System
Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Network of international distributors across the United States, Europe, Mexico, Singapore, India, Australia, New Zealand, and additional countries enabling global presence in 59 countries.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Niche manufacturer of portable oxygen concentrators (Oxlife Independence) competing in the same HME provider channel. Comparable product category with a smaller commercial footprint than Inogen.

TypeDirect peer
Description

Direct competitor across Inogen's respiratory portfolio — portable and stationary oxygen concentrators, CPAP devices and masks. Operates a similar B2B channel to HME providers and shares overlap in COPD and sleep apnea patient populations.

TypeDirect peer
Description

Global leader in sleep apnea and respiratory care, including CPAP masks that directly compete with Inogen's Aurora CPAP mask portfolio. Comparable B2B motion into HME/respiratory channels and overlapping patient base in chronic respiratory disease.

4Drive DeVilbiss Healthcare
TypeDirect peer
Description

Manufactures portable and stationary oxygen concentrators distributed through the same HME provider channel as Inogen. Closely comparable product portfolio and customer base, particularly across the U.S. durable medical equipment market.

TypeDirect peer
Description

Oxygen therapy specialist (a Chart Industries business) producing portable and stationary oxygen concentrators for home and clinical use. Directly comparable technology stack, customer base, and distribution model to Inogen's POC business.

TypeEmerging player
Description

Emerging competitor in portable oxygen concentrators with the X-PLOR and DISCOV-R product lines. Targets the same POC patient and HME channel as Inogen but with a smaller installed base and narrower product range.

TypeDirect peer
Description

Holds the former Invacare respiratory portfolio — including portable oxygen concentrators and sleep therapy devices — and reaches the same HME providers as Inogen. Closely comparable channel and end-user overlap.

TypeBroad incumbent
Description

Broader respiratory care incumbent with CPAP mask and humidification products overlapping with Inogen's Aurora masks and Rove POC ecosystem. Larger, more diversified portfolio with global hospital and home care distribution.

TypeEmerging player
Description

Chinese medical device company in oxygen concentrators, sleep therapy, and respiratory care — a competitor in international markets where Inogen is expanding (15–18% growth) and a current investor in Inogen, signaling strategic interest in the POC market.

TypeBroad incumbent
Description

Broader medtech incumbent whose Respiratory, GI & Informatics division overlaps with Inogen's addressable disease states. Inogen's new board member Vafa Jamali is a former Medtronic executive, reflecting category adjacency rather than direct product overlap.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Inogen

Portable Oxygen Concentratorsprovider.inogen.com

Inogen (NASDAQ:INGN) is a publicly traded medical device manufacturer founded in 2001 that designs, produces, and sells portable oxygen concentrators, stationary oxygen systems, CPAP masks, and airway clearance technology, selling primarily through B2B channels to Home Medical Equipment providers and international distributors across 59 countries.

What Inogen does

Inogen, Inc. (NASDAQ:INGN) is a publicly traded medical device company founded in 2001 and headquartered in Beverly, Massachusetts, that manufactures portable oxygen concentrators (POCs) and related respiratory care equipment. Its core technology centers on proprietary Intelligent Delivery Technology, a pulse-dose oxygen delivery system that detects inspiration and delivers oxygen within the first 250 milliseconds of breath, with replaceable sieve beds that customers can swap in the field. The current product portfolio includes the Inogen One G5, Rove 4, and Rove 6 portable concentrators, the Voxi 5 stationary concentrator, the newly launched Aurora CPAP mask family for sleep apnea, and the Simeox airway clearance technology acquired from Physio-Assist in 2023. The Inogen Connect mobile app provides fleet management, device monitoring, and software updates over Bluetooth.

Inogen sells primarily through a B2B go-to-market model targeting Home Medical Equipment (HME) providers in the United States and international distributors across 59 countries, with pricing conducted via quote-based sales rather than published list pricing. Revenue is generated predominantly through hardware sales of POCs and accessories, supplemented by US rental income (which declined 8% in the most recent reporting period) and an emerging CPAP accessories stream. The company has sold more than one million POC units cumulatively, employs 251-500 people, and operates a European subsidiary (Inogen Europe BV) in the Netherlands. Inogen is debt-free with $120.9 million in cash as of Q4 2025 and holds 31 US patents plus one Canadian patent covering its core device technology.

FY2025 revenue was approximately $349 million (4% YoY growth), with Q1 2026 revenue of $85.1 million and FY2026 guidance of $366-$373 million. International revenue grew 15-18% YoY, and unit volume grew approximately 20% on market conversion from traditional oxygen tanks to POCs. The company remains EBITDA-negative (-$9.5M in 2025) but has shown a clear profitability turnaround from 2023's -$45.7M EBITDA loss. Recent strategic activity includes the 2023 Physio-Assist acquisition, the January 2026 Aurora CPAP launch, the May 2026 Brazil launch of Rove 6, a $30 million share repurchase program authorized in February 2026, and leadership changes in early 2026 (new CFO, CMO, VP B2B Sales, and board director Vafa Jamali) associated with a cooperation agreement with activist investor Kent Lake Partners LP.

Inogen firmographics

Firmographics
Name
Inogen
Legal name
Inogen, Inc.
Website
https://provider.inogen.com
Company type
Public
Founded year
2001
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Inogen (NASDAQ:INGN) is a publicly traded medical device manufacturer founded in 2001 that designs, produces, and sells portable oxygen concentrators, stationary oxygen systems, CPAP masks, and airway clearance technology, selling primarily through B2B channels to Home Medical Equipment providers and international distributors across 59 countries.
Ownership category
akta.pro rank

Inogen industry classification

Industry
Product category
Portable Oxygen Concentrators
NAICS
Home Health Equipment Rental (532283), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHSABAKAD
Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
SECONDARYHLAHAGAG
Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Portable oxygen concentrators
  • Respiratory care devices
  • Home medical equipment
  • Oxygen therapy systems
  • Medical device manufacturing

Where Inogen is headquartered

Location

Headquarters

HQ city
Beverly
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Inogen business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Portable Oxygen Concentrator Sales: Inogen generates revenue primarily through the sale of portable oxygen concentrators (POCs) to HME providers. The company sells a range of products including the Inogen One G5, Rove 4, Rove 6, and Voxi 5 stationary concentrators, along with accessories and replacement parts.
  2. Oxygen Therapy Rentals: The company generates revenue from rentals of oxygen therapy equipment in the U.S. market, though U.S. rentals declined 8% due to fewer patients on service.
  3. Accessories and Replacement Parts: Sales of accessories including batteries, power supplies, carry bags, backpacks, and replacement columns/sieve beds for the POC product line.
  4. CPAP Masks: Aurora CPAP masks launched in January 2026, representing the company's expansion into the sleep apnea market with full face, nasal cushion, and nasal pillows options.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goContact sales for all product pricing

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Inogen product offering

Product offering

Core offering

Inogen manufactures and sells portable oxygen concentrators (POCs), stationary oxygen concentrators, CPAP masks, and airway clearance technology primarily through a B2B model targeting Home Medical Equipment (HME) providers in the US and internationally across 59 countries. The company's core POC lineup includes the Inogen One G5, Rove 4, and Rove 6 systems, all featuring proprietary Intelligent Delivery Technology for breath-triggered oxygen delivery. Inogen is also an accredited homecare provider offering oxygen therapy equipment rentals directly to US patients.

Product overview

Inogen provides a portfolio of respiratory care products centered on portable oxygen concentrators (POCs) and stationary oxygen systems, supplemented by sleep apnea masks and airway clearance technology acquired through the Physio-Assist acquisition. The core portable oxygen concentrator lineup includes the Inogen One G5 (6-flow settings, up to 1260 ml/min), Rove 4 (4-flow settings, up to 840 ml/min), and Rove 6 (6-flow settings, up to 1260 ml/min), all featuring proprietary Intelligent Delivery Technology for breath-triggered oxygen delivery. The stationary Voxi 5 delivers continuous flow oxygen (1-5 L/min) for home use. The Aurora CPAP mask family (F1 Full Face, N1 Nasal, P1 Nasal Pillows) marks Inogen's entry into sleep apnea therapy. The acquired Simeox technology addresses airway clearance for bronchiectasis. The Inogen Connect mobile app enables patients and providers to monitor device health, track fleet operations, and receive software updates.

Differentiator

Problem solved

Functional benefit

Brands

  • Aurora Masks: CPAP masks for obstructive sleep apnea treatment, including F1 Full Face, N1 Nasal Cushion, and P1 Nasal Pillows models
  • Voxi 5
  • Rove
  • Inogen One G5
  • Inogen Connect

Products and services

  • Inogen One G5 System Portable oxygen concentrator with six flow settings delivering up to 1260 ml of medical-grade oxygen per minute. Weighs 2.2 kg (4.7 lbs) with single battery. Features Intelligent Delivery Technology with breath detection for oxygen delivery within first 250 milliseconds of inspiration. Expected service life up to 8 years.
  • Inogen Rove 6 System

Quantifiable outcome

  • 19% lower mortality risk associated with high mobility POC group vs low mobility POC group
  • +3 more outcomes

Companies that use Inogen

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Inogen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Inogen partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • International DistributorscoreChannel Partner/ Reseller/ DistributorNetwork of international distributors across the United States, Europe, Mexico, Singapore, India, Australia, New Zealand, and additional countries enabling global presence in 59 countries.

Scale indicators17 records

Recent moves7 records

Expansion highlights5 records

Inogen competitors and assessment

Company assessment

Emerging players

  • O2 Concepts: Niche manufacturer of portable oxygen concentrators (Oxlife Independence) competing in the same HME provider channel. Comparable product category with a smaller commercial footprint than Inogen.
  • Belluscura: Emerging competitor in portable oxygen concentrators with the X-PLOR and DISCOV-R product lines. Targets the same POC patient and HME channel as Inogen but with a smaller installed base and narrower product range.
  • Yuwell Medical: Chinese medical device company in oxygen concentrators, sleep therapy, and respiratory care — a competitor in international markets where Inogen is expanding (15–18% growth) and a current investor in Inogen, signaling strategic interest in the POC market.

Direct peers

  • Philips Respironics: Direct competitor across Inogen's respiratory portfolio — portable and stationary oxygen concentrators, CPAP devices and masks. Operates a similar B2B channel to HME providers and shares overlap in COPD and sleep apnea patient populations.
  • ResMed: Global leader in sleep apnea and respiratory care, including CPAP masks that directly compete with Inogen's Aurora CPAP mask portfolio. Comparable B2B motion into HME/respiratory channels and overlapping patient base in chronic respiratory disease.
  • Drive DeVilbiss Healthcare: Manufactures portable and stationary oxygen concentrators distributed through the same HME provider channel as Inogen. Closely comparable product portfolio and customer base, particularly across the U.S. durable medical equipment market.
  • Caire (Chart Industries): Oxygen therapy specialist (a Chart Industries business) producing portable and stationary oxygen concentrators for home and clinical use. Directly comparable technology stack, customer base, and distribution model to Inogen's POC business.
  • React Health (formerly 3B Medical / Invacare Supply): Holds the former Invacare respiratory portfolio — including portable oxygen concentrators and sleep therapy devices — and reaches the same HME providers as Inogen. Closely comparable channel and end-user overlap.

Broad incumbents

  • Fisher & Paykel Healthcare: Broader respiratory care incumbent with CPAP mask and humidification products overlapping with Inogen's Aurora masks and Rove POC ecosystem. Larger, more diversified portfolio with global hospital and home care distribution.
  • Medtronic (Respiratory Interventions): Broader medtech incumbent whose Respiratory, GI & Informatics division overlaps with Inogen's addressable disease states. Inogen's new board member Vafa Jamali is a former Medtronic executive, reflecting category adjacency rather than direct product overlap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Inogen social profiles

Digital presence

Inogen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Inogen leadership team

Management profile

Number of profiles

Profiles7 records

Inogen subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Inogen funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Inogen M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inogen

What does Inogen do?

Inogen manufactures and sells portable oxygen concentrators (POCs), stationary oxygen concentrators, CPAP masks, and airway clearance technology primarily through a B2B model targeting Home Medical Equipment (HME) providers in the US and internationally across 59 countries. The company's core POC lineup includes the Inogen One G5, Rove 4, and Rove 6 systems, all featuring proprietary Intelligent Delivery Technology for breath-triggered oxygen delivery. Inogen is also an accredited homecare provider offering oxygen therapy equipment rentals directly to US patients.

Is Inogen a public or private company?

Inogen is a public company. It is classified as public and is currently operating.

When was Inogen founded?

Inogen was founded in 2001. It employs 501 to 1,000 people.

Where is Inogen based?

Inogen is headquartered in Beverly, United States, in the North America region.

How does Inogen make money?

Four revenue lines are on record. Portable Oxygen Concentrator Sales are the primary driver. The others are oxygen Therapy Rentals, accessories and Replacement Parts and CPAP Masks.

Who are Inogen's main competitors?

Emerging players on record are O2 Concepts, Belluscura and Yuwell Medical. Direct peers are Philips Respironics, ResMed, Drive DeVilbiss Healthcare, Caire (Chart Industries) and React Health (formerly 3B Medical / Invacare Supply). Broad incumbents are Fisher & Paykel Healthcare and Medtronic (Respiratory Interventions).

Does Inogen have an API?

No public API is recorded for Inogen.

What industry is Inogen in?

Inogen's product category is Portable Oxygen Concentrators. Its primary akta.pro industry code is HLAHAGAD, Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC), with a secondary code of HSABAKAD, Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers). Its NAICS code is 532283 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StWhat You Need To Know About The Inogen, Inc. (NASDAQ:INGN) Analyst Downgrade TodayAnalysts downgraded Inogen, cutting 2027 revenue estimates to $308m from $373m, implying a 13% decline. The consensus expects an annualized 11% revenue drop through 2027, worse than the industry's 7.5% growth forecast.YahooInogen: Q3 Earnings SnapshotInogen Inc. reported a third-quarter loss of $16.2 million, or 61 cents per share, with adjusted losses of 56 cents. The company posted revenue of $77.2 million and expects full-year revenue between $298 million and $301 million.Investing.comInogen names Andy Reding as CEO, replacing Kevin SmithInogen Inc. appointed Andy Reding as president and CEO, replacing Kevin Smith. Reding, who joined as COO in July, brings over 30 years of medical technology experience, including roles at Viant Medical and Hillrom. The company will separately announce Q3 2026 financial results.Seeking AlphaInogen appoints COO Andy Reding as new CEO (INGN:NASDAQ)Inogen appointed Chief Operating Officer Andy Reding as president and chief executive officer. Reding will also serve as a member of the company's board of directors.MarketBeatInogen (INGN) Set to Release Earnings on ThursdayInogen is set to release Q3 2026 earnings after market close on November 5th, with analysts expecting a loss of $0.11 per share and revenue of $92.23 million. The company's last quarterly results showed a loss of $0.14 per share and revenue of $95.08 million. Analysts have a consensus rating of Moderate Buy.Ticker ReportContrasting Inogen (NASDAQ:INGN) & QT Imaging (NASDAQ:QTI)QT Imaging and Inogen are compared on analyst ratings, dividends, earnings, valuation, profitability, risk, and institutional ownership. Inogen beats on 9 of 15 factors, but QT Imaging has higher probable upside at 231.95% versus Inogen's lower P/E ratio.Business Wire BlogInogen to Report Third Quarter 2026 Financial Results on November 5, 2026Inogen, Inc. will report its third quarter 2026 financial results after market close on November 5, 2026, and will host a conference call at 5:00 p.m. Eastern Time. The company will also provide a live webcast and archived recording of the call.YahooInogen to Report Third Quarter 2026 Financial Results on November 5, 2026Inogen, Inc. announced it will report third quarter 2026 financial results after market close on November 5, 2026, and host a conference call at 5:00 p.m. Eastern Time. The call will be available via dial-in and webcast, with a replay accessible through November 12, 2026.TradingViewInogen to Report Third Quarter 2026 Financial Results on November 5, 2026Inogen, Inc. will report its third quarter 2026 financial results after market close on November 5, 2026, and host a conference call at 5:00 p.m. Eastern Time. The call will be available via dial-in and webcast, with a replay accessible through November 12, 2026.Seeking AlphaInogen: Selling Rental Is A Start, Continued Work To Be Done (NASDAQ:INGN)Inogen sold its U.S. oxygen rental assets for $25 million, expected to be accretive to growth and adjusted operating income. The company reported 2025 revenue up just 4% and a modest $4 million EBITDA guidance for 2026, trailing inflation. The analyst maintains a neutral stance, awaiting clearer margin improvement.